News Palisade Bio, Inc.

Equities

SNCA

US6963894026

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
6.05 ^USD	-2.89%		+28.45%	-31.64%

Apr. 23	Palisade Bio Collaborating With Strand Life Sciences on Ulcerative Colitis Therapy	MT
Apr. 23	Palisade Bio, Inc. Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach	Apr. 24	AQ
Palisade Bio Collaborating With Strand Life Sciences on Ulcerative Colitis Therapy	Apr. 23	MT
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach	Apr. 23	AQ
Palisade Bio, Inc. Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach	Apr. 23	CI
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 in Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients Stool	Apr. 17	AQ
Sector Update: Health Care Stocks Edge Up Tuesday Afternoon	Apr. 16	MT
Palisade Bio Shows Bioactivation of PALI-2108 in Study; Shares Rise	Apr. 16	MT
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool	Apr. 16	AQ
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients? Stool	Apr. 16	CI
Palisade Bio to Participate in the Virtual Investor Lunch Break Event	Apr. 11	AQ
Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™	Apr. 10	AQ
Reverse Split: 1 of 15	Apr. 07	FA
Palisade Bio Announces 1-for-15 Reverse Stock Split	Apr. 03	AQ
North American Morning Briefing : Stocks Seen -2-	Apr. 02	DJ
Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate Update	Mar. 27	AQ
Palisade Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Palisade Bio, Inc. Announces Resignation of Mary Ann Gray as Member of the Board	Mar. 06	CI
Palisade Bio to Present at Digestive Disease Week (DDW) 2024	Feb. 15	AQ
Palisade Bio Names Donald Williams as Chairman	Feb. 13	MT
Palisade Bio Provides Corporate Update and Reiterates Guidance	Feb. 13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Palisade Bio, Inc.

Equities

SNCA

US6963894026

Summary

Filters